Dr Kazem Rahimi (Professor of Cardiovascular Medicine and Population Health, University of Oxford, Oxford, UK) kindly shared his thoughts on the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC), its aims, and the benefits of antihypertensive medicines in older people from the virtual ESC Congress 2021.
Questions
- Could you tell us a little about the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC) and its aims? (0.11)
- What is known about the benefits of antihypertensive medicines in older people? (0.39)
- What were the aims and design of your study investigating the age-specific effects of blood pressure-lowering for prevention of cardiovascular disease? (1.12)
- What have been the study findings to date? (1.47)
- What are the implications of these findings for clinical practice? (2.52)
Speaker disclosures: Dr Kazem Rahimi has nothing to declare in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media and conducted by Heather Hall.
Filmed during a remote video call with Dr Kazem Rahimi as a highlight of ESC 2021, September 2021.
